This $7,250,000 federal Project Grant award, funded by the National Institute of Standards and Technology (NIST) under the Congressionally-Identified Projects program (CFDA 11.617), will enable the University of Delaware to procure biopharmaceutical manufacturing equipment at the pilot/clinical scale. The purpose is to establish a testbed for benchmarking current and future biopharmaceutical manufacturing innovations, as well as to support workforce development training activities, within the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) ecosystem. The award covers the procurement, installation, and commissioning of equipment such as cold storage, bioreactors, filtration systems, and chromatography systems. This testbed is envisioned to eventually be housed in the planned Securing American Biomanufacturing Research and Education (SABRE) Center and will be accessible to partners and scientists across the NIIMBL network. The award period is from October 1, 2024 to September 30, 2025.
Mod # | Description | Reason For Modification | Federal Obligation (Click to sort descending) | Date (Click to sort ascending) |
|---|---|---|---|---|
| Not listed | $7.3m | 9/5/24 |